• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有哌啶结构部分的螺环杂环作为抗利什曼原虫活性的潜在支架:合成、生物学评价和研究。

Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and studies.

机构信息

Chemistry Department, Faculty of Science, Sohag University, Sohag, Egypt.

High Institute of Public Health, Alexandria University, Alexandria, Egypt.

出版信息

J Enzyme Inhib Med Chem. 2023 Dec;38(1):330-342. doi: 10.1080/14756366.2022.2150763.

DOI:10.1080/14756366.2022.2150763
PMID:36444862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11003478/
Abstract

New spiro-piperidine derivatives were synthesised via the eco-friendly ionic liquids in a one-pot fashion. The antileishmanial activity against promastigote and amastigote forms highlighted promising antileishmanial activity for most of the derivatives, with superior activity compared to miltefosine. The most active compounds and exhibited sub-micromolar range of activity, with IC values of 0.89 µM and 0.50 µM, respectively, compared to 8.08 µM of miltefosine. Furthermore, the antileishmanial activity reversal of these compounds folic and folinic acids displayed comparable results to the positive control trimethoprim. This emphasises that their antileishmanial activity is through the antifolate mechanism targeting DHFR and PTR1. The most active compounds showed superior selectivity and safety profile compared to miltefosine against VERO cells. Moreover, the docking experiments of and against -PTR1 rationalised the observed activities. Molecular dynamics simulations confirmed a stable and high potential binding to -PTR1.

摘要

新型螺环哌啶衍生物通过绿色离子液体在一锅法中合成。抗利什曼原虫活性对前鞭毛体和无鞭毛体形式的研究突出了大多数衍生物具有有希望的抗利什曼原虫活性,其活性优于米替福新。最活性化合物和表现出亚微摩尔范围内的活性,IC 值分别为 0.89µM 和 0.50µM,而米替福新的 IC 值为 8.08µM。此外,这些化合物对叶酸和叶酸盐的抗利什曼原虫活性逆转与阳性对照三甲氧苄氨嘧啶显示出可比的结果。这强调了它们的抗利什曼原虫活性是通过针对 DHFR 和 PTR1 的抗叶酸机制。与米替福新相比,最活性化合物对 VERO 细胞表现出更高的选择性和安全性。此外,对 -PTR1 的对接实验合理地解释了观察到的活性。分子动力学模拟证实了与 -PTR1 的稳定和高潜力结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/e92e149e7117/IENZ_A_2150763_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/9d4bc962e12b/IENZ_A_2150763_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/af2f368f2136/IENZ_A_2150763_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/c2f079612e4b/IENZ_A_2150763_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/f1e475ae5846/IENZ_A_2150763_SCH0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/55a7756b8860/IENZ_A_2150763_SCH0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/3ee25edefb95/IENZ_A_2150763_SCH0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/bab8d95c4cd0/IENZ_A_2150763_SCH0006_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/8e1399b374cf/IENZ_A_2150763_SCH0007_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/cfa9480b7107/IENZ_A_2150763_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/e92e149e7117/IENZ_A_2150763_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/9d4bc962e12b/IENZ_A_2150763_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/af2f368f2136/IENZ_A_2150763_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/c2f079612e4b/IENZ_A_2150763_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/f1e475ae5846/IENZ_A_2150763_SCH0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/55a7756b8860/IENZ_A_2150763_SCH0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/3ee25edefb95/IENZ_A_2150763_SCH0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/bab8d95c4cd0/IENZ_A_2150763_SCH0006_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/8e1399b374cf/IENZ_A_2150763_SCH0007_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/cfa9480b7107/IENZ_A_2150763_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b7/11003478/e92e149e7117/IENZ_A_2150763_F0003_C.jpg

相似文献

1
Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and studies.具有哌啶结构部分的螺环杂环作为抗利什曼原虫活性的潜在支架:合成、生物学评价和研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):330-342. doi: 10.1080/14756366.2022.2150763.
2
Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation.四氢苯并[h]喹啉衍生物作为一种新型的抗利什曼原虫-抗疟化合物,具有抗结核活性:设计、合成与生物评价。
Eur J Med Chem. 2023 Sep 5;257:115534. doi: 10.1016/j.ejmech.2023.115534. Epub 2023 May 29.
3
New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations.新型吡唑并吡唑啉衍生物兼具抗疟和抗利什曼原虫活性:合成、生物评价和分子模拟研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2320-2333. doi: 10.1080/14756366.2022.2117316.
4
New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies.靶向二氢叶酸还原酶-胸苷酸合成酶和 PTR1 的新型抗利什曼原虫喹啉连接异吲哚酮衍生物:设计、合成及分子模拟研究
Eur J Med Chem. 2023 Jan 15;246:114959. doi: 10.1016/j.ejmech.2022.114959. Epub 2022 Nov 24.
5
Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.某些芳基烟酰基与芳基(硫)缩氨基脲的共轭物的合成、体外生物学评价和计算机研究作为一类新型抗利什曼原虫药物。
Eur J Med Chem. 2019 Oct 1;179:335-346. doi: 10.1016/j.ejmech.2019.06.051. Epub 2019 Jun 24.
6
Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: Design, synthesis and computational studies.通过一些新的香豆素-1,2,3-三唑来调节利什曼原虫的喋呤代谢机制:设计、合成与计算研究。
Eur J Med Chem. 2023 May 5;253:115333. doi: 10.1016/j.ejmech.2023.115333. Epub 2023 Apr 5.
7
Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents.合成、分子建模和一些吡唑衍生物的生物筛选作为抗利什曼原虫药物。
Future Med Chem. 2018 Oct 1;10(19):2325-2344. doi: 10.4155/fmc-2018-0058. Epub 2018 Sep 14.
8
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.新型噻唑嘧啶衍生物的设计、合成及体外生物学评价作为抗利什曼原虫化合物。
Arch Pharm (Weinheim). 2020 Aug;353(8):e1900325. doi: 10.1002/ardp.201900325. Epub 2020 Jun 2.
9
Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major.四氢嘧啶和二氢吡啶衍生物的合成及对抗利什曼原虫的生物评价。
Acta Parasitol. 2022 Mar;67(1):255-266. doi: 10.1007/s11686-021-00457-6. Epub 2021 Jul 19.
10
Benzimidazole derivatives endowed with potent antileishmanial activity.具有强大抗利什曼原虫活性的苯并咪唑衍生物。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):210-226. doi: 10.1080/14756366.2017.1410480.

引用本文的文献

1
Novel Benzenesulfonamide Derivatives of 5'-Aminospirotriazolotriazine Exhibit Anti-Inflammatory Activity by Suppressing Pro-Inflammatory Mediators: In Vitro and In Vivo Evaluation Using a Rat Model of Carrageenan-Induced Paw Edema.新型5'-氨基螺三唑并三嗪苯磺酰胺衍生物通过抑制促炎介质发挥抗炎活性:使用角叉菜胶诱导的大鼠足爪水肿模型进行的体外和体内评价
Biomedicines. 2025 Jul 15;13(7):1732. doi: 10.3390/biomedicines13071732.
2
Design, synthesis, in vitro and in silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase.新型哌啶衍生硫代缩氨基脲类化合物作为二氢叶酸还原酶抑制剂的设计、合成、体外及计算机模拟研究。
Sci Rep. 2024 Sep 30;14(1):22645. doi: 10.1038/s41598-024-72858-2.
3

本文引用的文献

1
New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations.新型吡唑并吡唑啉衍生物兼具抗疟和抗利什曼原虫活性:合成、生物评价和分子模拟研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2320-2333. doi: 10.1080/14756366.2022.2117316.
2
Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative.研究有前途的吡唑衍生物的抗炎和镇痛活性。
Eur J Pharm Sci. 2022 Jan 1;168:106080. doi: 10.1016/j.ejps.2021.106080. Epub 2021 Nov 21.
3
In vitro anti-Leishmania activity and molecular docking of spiro-acridine compounds as potential multitarget agents against Leishmania infantum.
Synthesis, docking and characterization of some novel 5-(S-alkyl)-1.3.4-thiadiazole-2-carboxamide derivatives as anti-inflammatory and antibacterial agents.
一些新型5-(S-烷基)-1,3,4-噻二唑-2-甲酰胺衍生物作为抗炎和抗菌剂的合成、对接及表征
BMC Chem. 2024 Jul 27;18(1):138. doi: 10.1186/s13065-024-01237-9.
4
Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents.硫脲功能化氨苯蝶啶衍生物作为抗利什曼原虫药物。
Future Med Chem. 2024 Aug 2;16(15):1485-1497. doi: 10.1080/17568919.2024.2359362. Epub 2024 Jul 2.
5
Synthesis, docking and biological evaluation of purine-5--isosteresas anti-inflammatory agents.嘌呤-5-等排体作为抗炎剂的合成、对接及生物学评价
RSC Adv. 2024 Jun 3;14(25):17785-17800. doi: 10.1039/d4ra02970d. eCollection 2024 May 28.
6
Synthesis, antileishmanial, antimalarial evaluation and molecular docking study of some hydrazine-coupled pyrazole derivatives.某些肼偶联吡唑衍生物的合成、抗利什曼原虫、抗疟评估及分子对接研究
BMC Chem. 2024 Jan 8;18(1):9. doi: 10.1186/s13065-023-01111-0.
7
Green synthesis, biological and molecular docking of some novel sulfonamide thiadiazole derivatives as potential insecticidal against Spodoptera littoralis.绿色合成、生物活性及分子对接研究一些新型磺胺噻二唑衍生物对斜纹夜蛾的杀虫活性
Sci Rep. 2023 Nov 6;13(1):19142. doi: 10.1038/s41598-023-46602-1.
8
Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design.蝶啶还原酶1的结构与动力学:与酶功能和药物设计相关的关键现象
Eur Biophys J. 2023 Oct;52(6-7):521-532. doi: 10.1007/s00249-023-01677-6. Epub 2023 Aug 22.
9
Natural-Product-Inspired Microwave-Assisted Synthesis of Novel Spirooxindoles as Antileishmanial Agents: Synthesis, Stereochemical Assignment, Bioevaluation, SAR, and Molecular Docking Studies.受天然产物启发的微波辅助新型螺环氧化吲哚类抗利什曼原虫剂的合成:合成、立体化学归属、生物评价、SAR 和分子对接研究。
Molecules. 2023 Jun 16;28(12):4817. doi: 10.3390/molecules28124817.
作为针对婴儿利什曼原虫的潜在多靶点药物的螺吖啶化合物的体外抗利什曼原虫活性及分子对接
Bioorg Med Chem Lett. 2021 Oct 1;49:128289. doi: 10.1016/j.bmcl.2021.128289. Epub 2021 Jul 24.
4
Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.三氟甲基取代的 3,5-双(亚苄基)-4-哌啶酮通过抑制 NF-кB 激活作为潜在的抗肝癌和抗炎药物。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1622-1631. doi: 10.1080/14756366.2021.1953996.
5
Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.借助丙型肝炎病毒 NS5B 棕榈亚基结合物促进 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp)药物研发:计算方法和基准测试。
Comput Biol Med. 2021 Jul;134:104468. doi: 10.1016/j.compbiomed.2021.104468. Epub 2021 May 11.
6
Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study.针对 SARS-CoV2 木瓜蛋白酶样蛋白酶的多种构象进行药物重定位:一项计算机研究。
Comput Biol Med. 2021 Apr;131:104295. doi: 10.1016/j.compbiomed.2021.104295. Epub 2021 Feb 24.
7
Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2.关于瑞德西韦与 SARS-cov-2 的 RNA 依赖性 RNA 聚合酶(RdRp)结合的机制见解。
Comput Biol Med. 2021 Feb;129:104156. doi: 10.1016/j.compbiomed.2020.104156. Epub 2020 Nov 27.
8
Natural and synthetic coumarins as antileishmanial agents: A review.天然香豆素和合成香豆素作为抗利什曼原虫药物:综述。
Eur J Med Chem. 2020 Oct 1;203:112514. doi: 10.1016/j.ejmech.2020.112514. Epub 2020 Jul 9.
9
Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases.针对氧化还原原生动物代谢中的关键酶——硫醇还原酶,开发治疗利什曼病和锥虫病的新药。
Molecules. 2020 Apr 21;25(8):1924. doi: 10.3390/molecules25081924.
10
Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.某些芳基烟酰基与芳基(硫)缩氨基脲的共轭物的合成、体外生物学评价和计算机研究作为一类新型抗利什曼原虫药物。
Eur J Med Chem. 2019 Oct 1;179:335-346. doi: 10.1016/j.ejmech.2019.06.051. Epub 2019 Jun 24.